Research Spacer image for layout

Tumour Angiogenesis

Mayerhofer K, Lozanov P, Bodner K, Bodner-Adler B, Obermair A, Kimberger O, Czerwenka K. Ki-67 and vascular endothelial growth factor expression in uterine leiomyosarcoma. Gynecol Oncol 2004;92:175-9.

Stimpfl M, Tong D, Fasching B, Schuster E, Obermair A, Leodolter S, Zeillinger R. Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer. Clin Cancer Res 2002;8:2253-9.

Bachtiary B, Selzer E, Knocke TH, Poetter R, Obermair A. Serum VEGF levels in patients undergoing primary radiotherapy for cervical cancer: impact on progression-free survival. Cancer Lett. 2002 May 28;179(2):197-203

Holzer G, Obermair A, Koschat M, Preyer O, Kotz R, Trieb K. Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with malignant bone tumors. Med Pediatr Oncol 2001; 36: 601-604.

Birner P, Schindl M, Obermair A, Breitenecker G, Kowalski H, Oberhuber G. Lymphatic microvessel density as a novel prognostic factor in early-stage invasive cervical cancer. Int J Cancer. 2001; 95: 29-33.

Birner P, Obermair A, Schindl M, Kowalski H, Breitenecker G, Oberhuber G. Selective immunohistochemical staining of blood and lymphatic vessel invasion in early-stage cervical cancer. Clin Cancer Res 2001; 7: 93-97.

Birner P. Schindl M, Obermair A, et al. Lymphatic microvessel density in epithelial ovarian cancer: its impact on prognosis. Anticancer Res 2000; 20: 2981-2985.

Hefler L, Tempfer C, Obermair A, et al. Serum concentrations of vascular endothelial growth factor in vulvar cancer. Clin Cancer Res 1999; 5: 2806-2809.

Obermair A, et al. Correlation of the serum concentration of vascular endothelial growth factor (VEGF) and hemoglobin levels in patients with epithelial ovarian cancer. Ann Oncol 1999; 10: 998 (letter).

Bancher-Todesca D, Rosen A, Graf A, Wasicky R, Hohlagschwandtner M, Rebhandl W, Heinze G, Breitenecker G, Gitsch G, Obermair A. Prognostic significance of tumor angiogenesis in primary fallopian tube cancer. Cancer Lett 1999; 141: 179-186.

Hefler L, Tempfer C, Kainz C, Obermair A. Serum concentrations of endostatin in patients with vulvar cancer. Gynecol Oncol 1999; 74: 151-152.

Hefler L, Obermair A, Tempfer C, van Houte M, Maenner G, Reinthaller A, Leodolter S, Kainz C. Serum concentrations of squmous cell carcinoma antigen in patients with vulvar intraepithelial neoplasia and vulvar cancer. Int J Cancer 1999; 84: 299-303.

Obermair A, et al. Prognostic significance of tumor angiogenesis in epithelial ovarian cancer. Cancer Lett 1999; 138: 175-182.

Obermair A, et al. Prognostic significance of tumour angiogenesis in endometrial cancer. Obst Gynecol 1999; 93: 367-371.

Tempfer C, Obermair A, Hefler L, Husler G, Gitsch G, Kainz C. Vascular Endothelial Growth factor serum concentrations in ovarian cancer. Obstet Gynecol 1998; 92: 360-363.

Obermair A, et al. Influence of intratumoral basic Fibroblast Growth Factor concentration on survival in ovarian cancer patients. Cancer Lett 1998; 130: 69-76.

Obermair A, et al. Concentration of Vascular Endothelial Growth Factor (VEGF) in the serum of patients with suspected ovarian cancer. Br J Cancer 1998; 77: 1870-1874.

Peters-Engl C, Medl M, Mirau M, Wanner C, Bilgi S, Sevelda P, Obermair A. Color-coded and spectral doppler flow in breast carcinomas-relationship with tumor microvasculature. Breast Cancer Res Treat 1998; 47: 83-89.

Obermair A, et al. Tumor angiogenesis in stage IB cervical cancer: correlation of microvessel density with survival. Am J Obstet Gynecol 1998;178: 314-319.

Obermair A, et al. The influence of vascular space involvement on the prognosis of patients with stage IB cervical carcinoma: Correlation of results from Hematoxylin and Eosin staining with results from immunostaining for Factor VIII-related antigen. Cancer 1998; 82: 689-696.

Obermair A, et al. Correlation of Vascular Endothelial Growth Factor Expression and Microvessel Density in Cervical Intraepithelial Neoplasia. J Natl Cancer Inst 1997; 89, 1212-1217.

Obermair A, et al. Vascular Endothelial Growth factor (VEGF) in human breast cancer: Correlation with disease-free survival. Int J Cancer 1997; 74: 455-458.

Bancher-Todesca D, Obermair A, et al. Angiogenesis in Vulvar Intraepithelial Neoplasia. Gynecol Oncol 1997; 64: 496-500.

Kohlberger P, Obermair A, et al. Quantitative immunohistochemistry of factor VIII-related antigen in breast carcinoma. Am J Clin Pathol 1996; 105: 705-710.

Obermair A, et al. Influence of Microvessel Density and Vascular Permeability Factor/ Vascular Endothelial Growth Factor (VPF/VEGF) Expression on Prognosis in Vulvar Cancer. Gynecol Oncol 1996; 63: 204-209.

Sliutz G, Tempfer C, Obermair A, et al. Serum evaluation of basic fibroblast growth factor in cervical cancer patients. Cancer Letters 1995; 94: 227-231.

Sliutz G, Tempfer C, Obermair A, et al. Serum evaluation of basic FGF in breast cancer patients. Anticancer Research 1995; 15: 2675-2678.

Kainz C, Speiser P, Wanner C, Obermair A, et al. Prognostic value of tumour microvessel density in cancer of the uterine cervix stage Ib to IIb. Anticancer Research 1995; 15: 1549-1552.

Obermair A, et al. Microvessel density and vessel invasion in lymph-node-negative breast cancer: effect on recurrence-free survival. Int J Cancer 1995; 62: 126-131.

Obermair A, et al. Tumorale Gefdichte bei Mammatumoren und ihr Einflu auf das rezidivfreie Intervall. Chirurg 1994; 65: 611-615. [German]

Obermair A, et al. Tumorgefinvasion beim Mammakarzinom: Hematoxylin-Eosin vs. Immunhistochemische Frbung gegen Faktor VIII-Antigen. Dtsch Med Woschr 1994, 119: 1491-1496.

Obermair A, et al. Influence of tumoral microvessel density on the recurrence-free survival in human breast cancer: Preliminary results. Onkologie 1994; 17: 44-49.

Kurz Ch, Obermair A, et al. Die Wertigkeit des Faktors "Gefinvasion" fr die Prognose des Mammakarzinoms. Geburtsh Frauenheilk 1994; 54: 295-299. [German]

Obermair A, et al. Vessel invasion predicts early recurrence in breast cancer: Preliminary results. Onkologie 1993; 16: 434-437.